Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J9047
    Short Description Injection, carfilzomib, 1 mg
    Long Description Injection, carfilzomib, 1 mg
    Pricing indicator 51
    Coverage code C
    ASC payment group code YY
    BETOS2 code O1D
    Action code N
    Type of service 1
    Effective date 2014-01-01
    Date Added 2014-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    76075010101 J9047 Injection, carfilzomib, 1 mg Kyprolis AMGEN USA, INC. 1 mg 1 1 60 60
    76075010201 J9047 Injection, carfilzomib, 1 mg Kyprolis AMGEN USA, INC. 1 mg 1 1 30 30
    76075010301 J9047 Injection, carfilzomib, 1 mg Kyprolis AMGEN USA, INC. 1 MG 1 1 10 10
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    HCPCS Billing Calculator

    Dosage given to patient (per dose)
    HCPCS Dosage 1 MG
    HCPCS/CPT Billing Units 1
    Total doses ordered
    Billing Units 1

    Drug Details

    • Carfilzomib injection is used alone and in combination with other medications to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with other medications. Carfilzomib is in a class of medications called proteasome inhibitors. It works by stopping or slowing the growth of cancer cells in your body.